Literature DB >> 8543586

Regional chemotherapy: revisited.

M Markman.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8543586     DOI： 10.1007/bf01203066

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  8 in total

Review 1.  Intraperitoneal chemotherapy.

Authors:  M Markman
Journal:  Semin Oncol       Date:  1991-06       Impact factor: 4.929

2.  Intraperitoneal salvage chemotherapy in ovarian cancer: who is left to treat?

Authors:  R F Ozols
Journal:  Gynecol Oncol       Date:  1992-04       Impact factor: 5.482

3.  Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.

Authors:  M Markman; B Reichman; T Hakes; W Jones; J L Lewis; S Rubin; L Almadrones; W Hoskins
Journal:  J Clin Oncol       Date:  1991-10       Impact factor: 44.544

4.  Intraperitoneal therapy in ovarian cancer: time's up.

Authors:  R F Ozols
Journal:  J Clin Oncol       Date:  1991-02       Impact factor: 44.544

5.  Pharmacologic rationale for regional drug delivery.

Authors:  J M Collins
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

6.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

Authors:  N Kemeny; J Daly; B Reichman; N Geller; J Botet; P Oderman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

7.  Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors.

Authors:  L G Feun; S Wallace; D J Stewart; V P Chuang; W K Yung; M E Leavens; M A Burgess; N Savaraj; R S Benjamin; S E Young
Journal:  Cancer       Date:  1984-09-01       Impact factor: 6.860

8.  Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

Authors:  T G Allen-Mersh; S Earlam; C Fordy; K Abrams; J Houghton
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.